Article
Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy.
European journal of heart failure - 1 Oct 2024
Scolari Fernando L, Brahmbhatt Darshan, Abelson Sagi, Lee Deacon, Kim Raymond H, Pedarzadeh Ali, Sakhnini Ali, Adler Arnon, Chan Raymond H, Dick John E, Rakowski Harry, Billia Filio
Abstract excerpt
AIMS: The heterogeneous phenotype of hypertrophic cardiomyopathy (HCM) is still not fully understood. Clonal haematopoiesis (CH) is emerging as a cardiovascular risk factor potentially associated with adverse clinical events. The prevalence, phenotype and outcomes related to CH in HCM patients were evaluated. METHODS AND RESULTS: Patients with HCM and available biospecimens from the Peter Munk Cardiac Centre...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
